Informasjon

Irritabel tarm

Vil du vite mer?

Fordøyelsen, animasjon
Koloskopi
FODMAP-redusert diett hjelper mot irritabel tarm
FODMAP-reduserte matvarer
FODMAP - kostråd fra Haukeland sykehus
Å leve med irritabel tarm - intervju
Dagbok over kost og mageplager
Pepperminteolje
Irritabel tarm - for helsepersonell
Pasientforening: Landsforeningen mot fordøyelsessykdommer: www.lmfnorge.no

Vil du vite mer?

Få tilgang på artikkelen om dette temaet fra Legehandboka.no

Artikkelen inneholder all informasjon norske allmennleger bruker i sitt daglige arbeid.

Jeg har lest og akseptert Brukervilkår ved kjøp av NEL-dokumenter

Dette dokumentet er basert på det profesjonelle dokumentet "Irritabel tarm-syndrom". Referanselisten for dette dokumentet vises nedenfor.

Snyder N. Irritable bowel syndrome. BMJ Best Practice, last updated Mar 20, 2017. bestpractice.bmj.com
Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480-1491. PubMed
Vandvik, P. O. and Lydersen S, Farup PG. Prevalence, impact and comorbidity of IBS in Norway. Scand J Gastroenterol 2006; 41: 650-6. PubMed
Vandvik PO, Kristensen P, Aabakken L, Farup PG. Abdominal complaints in general practice. Scand J Prim Health Care 2004; 22: 157-62. PubMed
Agrawal A, Houghton LA, Reilly B, et al. Bloating and distension in irritable bowel syndrome: the role of gastrointestinal transit. Am J Gastroenterol 2009; 104:1998. PubMed
Lehrer JK. Irritable bowel syndrome. Medscape, last updated Apr 04, 2017. emedicine.medscape.com
Vandvik PO, Wilhelmsen I, Ihlebaek C, Farup PG. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther 2004; 20: 1195-203. PubMed
Lawal A, Kern M, Sidhu H, et al. Novel evidence for hypersensitivity of visceral sensory neural circuitry in irritable bowel syndrome patients. Gastroenterology 2006; 130:26. Gastroenterology
Dorn SD, Palsson OS, Thiwan SI, et al. Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity. Gut 2007; 56:1202. Gut
Carroccio A, Mansueto P, Iacono G, et al. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity. Am J Gastroenterol 2012; 107: 1898-906. PubMed
Ford AC, Vandvik PO. Irritable bowel syndrome: dietary interventions. Systematic review 410. BMJ Clinical Evidence 2015.
Rej A, Sanders DS. Gluten-free diet and its ‘cousins’ in irritable bowel syndrome. Nutrients. 2018 Nov; 10(11): 1727. www.ncbi.nlm.nih.gov
Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. Journal of Gastroenterology and Hepatology 2010; 25: 252-8. PubMed
Berstad A, Valeur J, Lillestøl K, et al, Matoverfølsomhet – et paradigmeskifte?, Allergi i praksis, 1/2011.
Biesiekierski JR, Peters SL, Newnham ED, et al. No effects of gluten in patients with self-reported non-celilac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroeneterology 2013; 145: 320-8. PubMed
Melchior C, Gourcerol G, Dechelotte P, et al. Symptomatic fructose malasorption in irritable bowel syndrome: A prospective study. Un Eur Gastroenterol J 2014; 2: 131-7. doi: 10.1177/2050640614521124 DOI
Gibson PR, Newnham E, Barrett JS, Shepherd SJ, Muir JG. Review article: fructose malabsorption and the bigger picture. Aliment Pharmacol Ther 2007; 25: 349-63. PubMed
Thabane M, et al. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2007; 26: 535-44. PubMed
Schmulson MJ, Drossman DA. What is new in Rome IV. J Neurogastroenterol Motil 2017; 23 (2): 151-63.
Cristofori F, Fontana C, Magista A, et al. Increased prevalence of celiac disease among pediatric patients with irritable bowel syndrome. A 6-year prospective chort study. JAMA Pediatr 2014. doi:10.1001/jamapediatrics.2013.4984 DOI
Carroccio A, Mansueto P, Iacono G, et al. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: Exploring a new clinical entity. Am J Gastroenterol, 2012. doi:10.1038/ajg.2012.236 DOI
Rostom A, Dubé C, Cranney A, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005; 128 (4 Suppl 1): 38-46.
Waugh N, Cummins E, Royle P, et al. Review: Calprotectin testing differentiates inflammatory bowel disease from the irritiable bowel syndrome. Ann Intern Med 2014; 160: JC13. doi:10.7326/0003-4819-160-8-201404150-02013 DOI
Menees SB, Powell C, Kurlander J, et al. A Meta-Analysis of the Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin, and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS. Am J Gastroenterol 2015; 110: 444-54. doi:10.1038/ajg.2015.6 DOI
Maagaard L, Ankersen DV, Vegh Z, et al. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol 2016; 22: 4009-19. pmid:27099444 PubMed
NICE guideline. Irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care. NICE guideline CG61, 2015.
Everitt HA, Landau S, O'Reilly G, et al. Assessing telephone-delivered cognitive–behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial. Gut, published online first: 10 April 2019. gut.bmj.com
Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949-58. doi: 10.1001/jama.2015.0954 DOI
Robinson A, Lee V, Kennedy A, et al. A randomised controlled trial of self-help interventions in patients with a primary care diagnosis of irritable bowel syndrome. Gut 2006; 55: 643-8. Gut
Staudacher HM1, Whelan K, et.al. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet, Oct 2011; 24(5): 487-95.
Halmos E, Power V, et.al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014; 146: 67-75. Gastroenterology
Dionne J, Ford AC, Yuhong Y et al. A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome. Am J Gastroenterol 2018. pmid:30046155 PubMed
Ford AC, Talley NJ, Spiegel BM, et al. Effect of fibre, antispasmodics, and peppermintoil in the treatment of irritabel bowel syndrome: systematic review and meta-analysis. BMJ 2008; 337: a2313. BMJ (DOI)
Moayyedi P, Quigley EM, Lacy BE, et al. The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol. 2014 Sep;109(9):1367-74. PMID: 25070054 PubMed
Bijkerk CJ, de Wit NJ, Muris JWM, et al. Soluble og insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ 2009; 339: b3154. BMJ (DOI)
Moayyedi P, Ford AC, Talley NJ, et al.The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010; 59: 325-32. Gut
Rao S, Lembo AJ, Shiff SJ, et al. A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation. Am J Gastroenterol 2012 Sep 18. pmid:22986440 PubMed
Shah ED, Kim HM, Schoenfeld P. Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2018. PMID: 29380823 PubMed
Ford AC, Quigley EM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: Systematic review and meta-analysis. Am J Gastroenterol 2014 Oct; 109:1547 doi:10.1038/ajg.2014.202 DOI
Biekiesiekierski JR, Newbham ED, Irving PM, et al. Gluten causes gastrointetinal symptoms in subjects without celiac disease: a double-blind randomized placebo-contgrolled trial. Am J Gastroenterol 2011; 106: 508-14. PubMed
Layer P, Stanghellini V. Linaclotide for the management of irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2014; 39: 371-84. PubMed
Chey WD, Lembo AJ, Lavins BJ, et al. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Am J Gastroenterol 2012 Sep 18. pmid:22986437 PubMed
Brenner DM, Fogel R, Dorn SD, et al. Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials. Am J Gastroenterol 2018. pmid:29545635 PubMed
Shin A, Camilleri M, Kolar G, et al. Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation. Aliment Pharmacol Ther 2014; 39: 239-53. pmid: 24308797 PubMed
Ruepert L, Quartero AO, de Wit NJ, et al. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews 2011; 10: CD003460. Cochrane (DOI)
Statens legemiddelverk. Truberzi (eluksadolin) på blå resept. Publisert: 02.01.2018. legemiddelverket.no
Fukudo S, Kinoshita Y, Okumura T, et al. Ramosetron reduces symptoms of irritable bowel syndrome with diarrhea and improves quality of life in women. Gastroenterology. 2016: 150: 358-66. PMID: 26551550 PubMed
Ford AC, Talley NJ, Schoenfeld PS, et al. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 2009; 58: 367-78.
Statens Legemiddelverk (SLV). Nye anbefalinger ved bruk av metoklopramid. Juli 2013.
Liu JP, Yang M, Liu Y, Wei ML, Grimsgaard S. Herbal medicines for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD004116. DOI: 10.1002/14651858.CD004116.pub2. DOI
Garsed K, Chernova J, Hastings M, et al. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut 2013 Dec 12.
Song GH, Leng PH, Gwee KA, Moochhala SM, Ho KY. Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study. Gut 2005; 54: 1402-7. Gut
Tazzyman S, Richards N, Trueman AR, et al. Vitamin D associates with improved quality of life in participants with irritable bowel syndrome: outcomes from a pilot trial. BMJ Open Gastro 2015; 2:e000052 . doi:10.1136/bmjgast-2015-000052 DOI
Kaptchuk TJ, Kelley JM, Conboy LA, et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 2008; 336: 999-1003. PubMed
Saito YA, Prather CM, Van Dyke CT, Fett S, Zinsmeister AR, Locke GR. Effects of multidisciplinary education on outcomes in patients with irritable bowel syndrome. Clin Gastroenterol Hep 2004; 2: 576-84. PubMed
van der Veek PP, van Rood YR, Masclee AA. Clinical trial: short- and long-term benefit of relaxation training for irritable bowel syndrome. Aliment Pharmacol Ther 2007; 26: 943-52. PubMed
El-Salhy M, Hatlebakk JG, Gilja OH et al. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut 2019. Epub ahead of print. pmid:31852769 PubMed
Halkjær SI, Christensen AH, Lo BZS, et al Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study Gut Published Online First: 06 July 2018.
Longstreth GF, Yao JF. Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 2004; 126: 1665 - 73. Gastroenterology
Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med 1995;122:107-112. Annals of Internal Medicine

Meld deg på nyhetsbrev

Er du helsepersonell?

Ved å oppgi dette kan du få bedre tilpasset innhold om du har formell helsefaglig kompetanse

Mest lest i dag

For helsepersonell

Er treningsprogram med tøyninger gunstig ved fibromyalgi?

Fysisk trening er et av tiltakene med best effekt ved fibromyalgi. Hvilken betydning har tøyningsøvelser i et moderat intensivt treningsprogram?

Hud

Skabb

Skabb er en hudsykdom som skyldes en skabbmidd som graver ganger i huden og legger egg. Typiske symptomer er plutselig plagsom kløe, som oppleves mest intens om natten.

Barn

Kyssesyke, mononukleose

Kyssesyke, mononukleose, er en virusinfeksjon som oftest rammer barn og unge. Vanlige symptomer er kraftig halsbetennelse, hovne lymfekjertler, feber og generell sykdomsfølelse.

Irritabel tarm

Hopp til innhold

Vil du vite mer?

Er du helsepersonell?

Andre leste også dette

Avføringsprøver og irritabel tarm

Å leve med irritabel tarm

FODMAP-redusert diett hjelper mot irritabel tarm

Mest lest i dag

Er treningsprogram med tøyninger gunstig ved fibromyalgi?

Skabb

Kyssesyke, mononukleose